Obesity, Weight Loss Linked to Lung Cancer Immunotherapy Outcomes – Cancer Network
|
Obesity, Weight Loss Linked to Lung Cancer Immunotherapy Outcomes
Cancer Network Baseline body mass index (BMI) and weight loss during treatment with the programmed death 1 (PD-1)–targeting immune checkpoint inhibitors nivolumab and pembrolizumab appear to be associated with survival outcomes, according to a retrospective … |
